Definitive Healthcare (NASDAQ:DH) Now Covered by Stephens

Stephens started coverage on shares of Definitive Healthcare (NASDAQ:DH) in a research report sent to investors on Friday morning, Marketbeat reports. The firm issued an equal weight rating and a $5.00 price objective on the stock.

A number of other research analysts have also weighed in on DH. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. BTIG Research assumed coverage on Definitive Healthcare in a research report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective on the stock. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Price Performance

NASDAQ:DH opened at $4.18 on Friday. The stock has a 50 day moving average of $4.41 and a two-hundred day moving average of $4.69. Definitive Healthcare has a 12 month low of $3.19 and a 12 month high of $10.62. The firm has a market cap of $482.89 million, a P/E ratio of -1.35, a price-to-earnings-growth ratio of 3.29 and a beta of 1.40. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Insider Transactions at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now owns 433,830 shares of the company’s stock, valued at $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 14.84% of the company’s stock.

Institutional Trading of Definitive Healthcare

Institutional investors have recently bought and sold shares of the business. Point72 DIFC Ltd boosted its holdings in shares of Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after buying an additional 8,215 shares in the last quarter. Intech Investment Management LLC purchased a new stake in Definitive Healthcare in the third quarter valued at $55,000. Bleakley Financial Group LLC acquired a new position in Definitive Healthcare in the third quarter valued at $74,000. Glenmede Trust Co. NA grew its holdings in shares of Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after purchasing an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new stake in shares of Definitive Healthcare during the third quarter worth about $84,000. 98.67% of the stock is owned by hedge funds and other institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.